Regulatory T cells in cutaneous lesions of patients with Paracoccidioidomycosis
Carregando...
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Citação
MICROBIAL PATHOGENESIS, v.65, p.36-40, 2013
Resumo
Paracoccidioidomycosis (PCM) is a systemic mycosis caused by the dimorphic fungus Paracoccidioides brasiliensis, with high incidence in Brazil and very significant in Latin America. The disease is clinically classified as acute, subacute or chronic where the primary lesion initiates in the lungs and can spread to other organs such as the skin and mucous membranes. The lesions are characterized by granulomatous formation, organized according to the type of pattern of host immune response. We demonstrated and quantified by immunohistochemistry the expression of Foxp3, CD25, TGF-beta and IL-10 in thirty cutaneous lesions with different presentation of granulomatous response. Cells expressing Foxp3 and CD25 were increased in lesions with compact granulomas. The expression of TGF-beta and IL-10 was similar in all PCM lesions. As previous studies, our data suggest the correlation of Treg cells with the chronicity of the disease and the participation in suppressing mechanism as a possible source of IL-10. TGF-beta and IL-10, two important suppressor cytokines, are expressed in great amounts in the lesions but our results do not allow correlating with the differences in the granulomatous response.
Palavras-chave
Paracoccidioidomycosis, Skin, Regulatory T cells
Referências
- Abbas AK, 2012, IMUNOLOGIA CELULAR M, P326
- Benard G, 2008, MYCOPATHOLOGIA, V165, P209, DOI 10.1007/s11046-007-9065-0
- CARBONEL.LM, 1967, J BACTERIOL, V94, P213
- Cavassani KA, 2006, J IMMUNOL, V177, P5811
- Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102
- Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152
- de Brito T, 1994, Rev Inst Med Trop Sao Paulo, V36, P185
- Ferreira MC, 2010, INFECT IMMUN, V78, P4392, DOI 10.1128/IAI.00487-10
- Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904
- Gonzalez-Ochoa A., 1972, PAN AM S PAR P, P278
- Marques SA, 2009, MED CUT IBER LAT AM, V37, P159
- Moreira AP, 2008, J IMMUNOL, V180, P3049
- Neworal EPM, 2003, CYTOKINE, V21, P234, DOI 10.1016/S1043-4666(03)00051-6
- Pagliari C, 2003, AM J DERMATOPATH, V25, P107, DOI 10.1097/00000372-200304000-00003
- Pagliari C, 2011, MICROB PATHOGENESIS, V50, P263, DOI 10.1016/j.micpath.2010.12.008
- Pagliari C, 2002, MED MYCOL, V40, P407, DOI 10.1080/714031129
- Parise-Fortes MR, 2011, AN BRAS DERMATOL, V86, P516
- Pyzik M, 2007, J LEUKOCYTE BIOL, V82, P335, DOI 10.1189/jlb.1006644
- SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151
- Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017
- Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x